Operating Lease, Right-of-Use Asset of Aspira Women's Health Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aspira Women's Health Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Aspira Women's Health Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,029,000, a 100% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Aspira Women's Health Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,029,000 +$514,000 +100% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $1,077,000 +$518,000 +93% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $1,142,000 +$522,000 +84% 31 Mar 2025 10-Q 19 May 2025 2025 Q1
Q4 2024 $1,194,000 +$666,000 +126% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $515,000 -$85,000 -14% 30 Sep 2024 10-Q 19 Nov 2024 2024 Q3
Q2 2024 $559,000 +$217,000 +63% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $620,000 +$355,000 +134% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $528,000 +$246,000 +87% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $600,000 +$301,000 +101% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $342,000 +$27,000 +8.6% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $265,000 -$66,000 -20% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $282,000 -$64,000 -18% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $299,000 -$62,000 -17% 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $315,000 -$61,000 -16% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 $331,000 -$60,000 -15% 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 $346,000 -$60,000 -15% 31 Dec 2021 10-K/A 26 Oct 2023 2022 FY
Q3 2021 $361,000 -$60,000 -14% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $376,000 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $391,000 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 $406,000 +$354,000 +681% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $421,000 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q4 2019 $52,000 31 Dec 2019 10-K 31 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.